
Triple-strength semaglutide produces larger weight losses in landmark trials, but questions remain over tolerance and access
Two international randomized studies found a 7.2 mg weekly dose of semaglutide yielded greater weight loss than the currently approved 2.4 mg dose, with more frequent but mostly mild side effects





